Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

about

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish

P2860

Q37302207-43AD660E-B77B-4151-9665-31FB218780B6 Q38626654-2F2AC121-8275-4509-A5B9-06DCEFB65922

P2860

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Item

http://www.wikidata.org/entity/Q36844764

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Modification of 5-methoxy-N,N- ...... lying serotonergic mechanisms.

@en

type

Item

label

Modification of 5-methoxy-N,N- ...... lying serotonergic mechanisms.

@en

prefLabel

Modification of 5-methoxy-N,N- ...... lying serotonergic mechanisms.

@en

P1476

Modification of 5-methoxy-N,N- ...... lying serotonergic mechanisms.

@en

P2093

Ai-Ming Yu

http://www.w3.org/2001/XMLSchema#string

Hong-Wu Shen

http://www.w3.org/2001/XMLSchema#string

Xi-Ling Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions

Animal models of the serotonin syndrome: a systematic review

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Clinical toxicology of newer recreational drugs.

Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.

P304

608-615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHAREP.2016.01.008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26977821

http://www.w3.org/2001/XMLSchema#string

P932

4848137

http://www.w3.org/2001/XMLSchema#string

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

about

P2860

P2860

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932